Trial Profile
A Prospective Study Comparing Responsiveness Of The Six Spot Step Test (SSST) And The Timed 10 m Walk (T10mW) After Fampridine SR Treatment Among Multiple Sclerosis Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2017
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 05 Jan 2017 New trial record